Metastatic melanoma has become increasingly common in the North America over the past three decades, and death rates are rising faster than with other cancers. A new experimental immune therapy called Ipilimumab has been shown to dramatically increase the survival of patients with advanced stages of melanoma. The therapy works by helping the body's immune system fight tumors. Learn more here:
http://www.usatoday.com/news/health/2010-06-07-melanoma07_ST_N.htm
No comments:
Post a Comment